Key Summary: On June 16, 2025, BML Capital (8.4%) opposed Ikena’s merger with Inmagene, calling Inmagene overvalued and urging a winddown of Ikena and return of cash to shareholders.
Unlock the full analysis, investor activity breakdown, and complete commentary.
The best research idea generation service you've never heard of.
Fresh, unbiased data which allows independent consumers to formulate their own opinion. Unique, stellar and a bargain.
Raghu's research saves us an enormous amount of time. Our payback on subscribing is enormous.